101 related articles for article (PubMed ID: 1950386)
1. [Hemodilution, hemorheology and oxygen supply].
Ehrly AM
Acta Med Austriaca; 1991; 18 Suppl 1():3-8. PubMed ID: 1950386
[TBL] [Abstract][Full Text] [Related]
2. Optimal hematocrit in patients with intermittent claudication. Exercise-induced muscle tissue oxygen pressure after stepwise hemodilution.
Höffkes HG; Saeger-Lorenz K; Ehrly AM
Acta Med Austriaca; 1991; 18 Suppl 1():16-9. PubMed ID: 1950385
[TBL] [Abstract][Full Text] [Related]
3. [Hyper- or isovolemic hemodilution in patients with stage II peripheral arterial occlusive disease].
Kiesewetter H; Jung F; Blume J; Spitzer S; Birk A
Acta Med Austriaca; 1991; 18 Suppl 1():23-7. PubMed ID: 1719729
[TBL] [Abstract][Full Text] [Related]
4. Hematocrit dependent changes of muscle tissue oxygen supply in the lower limb muscle of patients with intermittent claudication.
Höffkes HG; Ehrly AM
Vasa; 1992; 21(4):350-4. PubMed ID: 1485467
[TBL] [Abstract][Full Text] [Related]
5. [Kinetic effects of 6% hydroxyethyl starch 200.000/0.6-0.66 in hypervolemic hemodilution].
Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
Acta Med Austriaca; 1991; 18 Suppl 1():20-2. PubMed ID: 1719728
[TBL] [Abstract][Full Text] [Related]
6. [Effect of a 10% and 6% hydroxyethyl starch solution (molecular weight 200,000/0.62) in comparison with a 10% dextran solution (molecular weight 40,000) on flow properties of blood and tissue oxygen pressure in patients with intermittent claudication].
Ehrly AM; Seebens H; Saeger-Lorenz K
Infusionstherapie; 1988 Oct; 15(5):181-7. PubMed ID: 2461906
[TBL] [Abstract][Full Text] [Related]
7. [Hypervolemic hemodilution with medium molecular-weight hydroxyethyl starch: effect of duration of administration on viscoelasticity of blood in IIa and IIb peripheral arterial occlusive disease].
Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
Acta Med Austriaca; 1991; 18 Suppl 1():45-7. PubMed ID: 1719731
[TBL] [Abstract][Full Text] [Related]
8. [Hemodilution in peripheral arterial occlusive disease--study comparing 3 different variants of hemodilution].
Weidinger P; Bilek M; Tekusch A
Vasa Suppl; 1990; 30():137-8. PubMed ID: 2075564
[No Abstract] [Full Text] [Related]
9. [Effect of hemodilution with 10% hydroxyethyl starch solution (MW 200,000/9.5) on the flow properties of blood, arterial blood gases and conjunctival oxygen partial pressure in patients with cerebral infarct].
Staedt U; Hütt M; Herrmann B; Seufzer U; Leweling H
Infusionstherapie; 1989 Jun; 16(3):107-12. PubMed ID: 2474508
[TBL] [Abstract][Full Text] [Related]
10. [Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease].
Kiesewetter H; Blume J; Jung F; Spitzer S; Gerhards M; Waldhausen P; Wenzel E
Wien Med Wochenschr; 1989 Sep; 139(17):396-401. PubMed ID: 2480029
[TBL] [Abstract][Full Text] [Related]
11. [Effect of stepwise hypervolemic versus isovolemic hemodilution in patients with intermittent claudication on muscle oxygen pressure during exercise].
Höffkes HG; Saeger-Lorenz K; Ehrly AM
Vasa; 1991; 20(2):109-18. PubMed ID: 1877329
[TBL] [Abstract][Full Text] [Related]
12. [Current status of hemodilution therapy].
Schneider R
Acta Med Austriaca; 1991; 18 Suppl 1():37-40. PubMed ID: 1950389
[TBL] [Abstract][Full Text] [Related]
13. [Hemodilution in peripheral arterial occlusive disease. Placebo controlled randomized double-blind study with hydroxyethyl starch or dextran].
Ernst E; Kollar L; Matrai A
Acta Med Austriaca; 1991; 18 Suppl 1():27-9. PubMed ID: 1719730
[TBL] [Abstract][Full Text] [Related]
14. Microcirculatory long-term effects after hypervolaemic and isovolaemic haemodilution in patients with intermittent claudication.
Höffkes HG; Ehrly AM
Presse Med; 1994 Apr; 23(14):657-60. PubMed ID: 8072963
[TBL] [Abstract][Full Text] [Related]
15. [Hemorheologic and clinical in vitro and in vivo studies of the effectiveness of isovolemic hemodilution using Gelafusal and Infukoll M40 in patients with peripheral arterial occlusive disease].
Pöhlmann G; Braumann A; Grohmann G
Vasa Suppl; 1991; 32():342-4. PubMed ID: 1722914
[No Abstract] [Full Text] [Related]
16. [Myocardial oxygen supply in hemodilution in patients with healthy hearts and heart surgery patients].
Klövekorn WP
Infusionstherapie; 1990 Apr; 17 Suppl 2():24-7. PubMed ID: 2197224
[TBL] [Abstract][Full Text] [Related]
17. [Conservative therapy of peripheral arterial occlusive diseases].
Alexander K
Z Kardiol; 1993; 82 Suppl 5():89-98. PubMed ID: 8154166
[TBL] [Abstract][Full Text] [Related]
18. [The effect of oral trapidil therapy on clinical and hemorheological parameters in arteriosclerosis obliterans in comparison to pentoxifylline--a pilot study].
Regenthal R; Voigt H; Reuter W; Preiss R
Z Gesamte Inn Med; 1991 Apr; 46(6):185-90. PubMed ID: 2063598
[TBL] [Abstract][Full Text] [Related]
19. [Heparin-induced extracorporeal LDL precipitation (HELP): a new therapeutic intervention in cerebrovascular diseases and peripheral arterial occlusive disease].
Walzl B; Walzl M; Lechner P; Lechner H; Cesnik H
Wien Med Wochenschr; 1993; 143(22):563-70. PubMed ID: 8154130
[TBL] [Abstract][Full Text] [Related]
20. [The therapy of peripheral obstructive arteriopathies: rational bases].
Laghi Pasini F; Camarda M; Di Perri T
Recenti Prog Med; 1993; 84(7-8):534-40. PubMed ID: 8356309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
